| 000 | 01790cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030847.0 | ||
| 008 | 130910s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2013.As.E | ||
| 100 | 0 | _aAsmaa Samir Mohamed Nofal | |
| 245 | 1 | 0 |
_aExpression of cyclin E2 and survivn in Egyptian acute leukemia patients / _cAsmaa Samir Mohamed Nofal ; Supervised Hanan Nour Rsalan , Manal Mohamed Makhlouf |
| 246 | 1 | 5 | _aالتعبير عن سيكلين إي {u٠٦ئ٢} و سيرفيفين فى المرضى المصريين الذين يعانون من سرطان الدم الحاد |
| 260 |
_aCairo : _bAsmaa Samir Mohamed Nofal , _c2013 |
||
| 300 |
_a234P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aAcute leukemias are clonal expansions of uncommitted or partially committed haematopoietic precursor cells . Abnormalities in the control of programmed cell death (apoptosis) play important role in leukemogenesis . Survivin is a member of inhibitor of apoptosis proteins (IAP) family . It prevents apoptosis by blocking caspase activity . Dramatic overexpression of survivin was demonstrated in solid tumours of pancreas oesophagus lung as well as in leukemias and lymphomas | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcute leukemias | |
| 653 | 4 | _aCyclin E2 | |
| 653 | 4 | _aSurvivn | |
| 700 | 0 |
_aHanan Nour Rsalan , _eSupervisor |
|
| 700 | 0 |
_aManal Mohamed Makhlouf , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c43455 _d43455 |
||